Clinical Edge Journal Scan

Presence of crystals in synovial fluid tied with higher disease burden in PsA


 

Key clinical point: The prevalence of crystals in the synovial fluid was higher in patients with psoriatic arthritis (PsA) than in those with gonarthrosis and indicated increased disease activity and declining physical abilities in patients with PsA.

Major finding: Synovial fluid crystals were present in a significantly higher proportion of patients with PsA vs. gonarthrosis (23.7% vs. 0%; P < .001), with the presence of crystals being associated with an increased odds of severe pain (odds ratio [OR] 157.25), high disease activity (OR 15.96), and severe disability (OR 13.60; all P < .001).

Study details: Findings are from a retrospective case-control study including 156 patients with PsA and 50 patients with gonarthrosis.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Geneva-Popova M et al. Assessment of crystals in the synovial fluid of psoriatic arthritis patients in relation to disease activity. Diagnostics (Basel). 2022;12(5):1260 (May 18). Doi: 10.3390/diagnostics12051260

Recommended Reading

Commentary: Factors in Psoriatic Arthritis Development and Treatment Response, June 2022
MDedge Rheumatology
Serum brodalumab levels linked with treatment outcomes in patients with psoriasis
MDedge Rheumatology
Izokibep improves multiple psoriatic arthritis symptoms in phase 2 study
MDedge Rheumatology
Biologics, Women, and Pregnancy: What’s Known?
MDedge Rheumatology
Bimekizumab calms psoriatic arthritis in phase 3 ‘BE’ trials
MDedge Rheumatology
Enthesitis resolves regardless of medication used in PsA
MDedge Rheumatology
Upadacitinib offers effective disease control in PsA
MDedge Rheumatology
Real-world study confirms benefits of golimumab on work productivity and QoL in PsA
MDedge Rheumatology
Identifying clinical characteristics of difficult-to-treat PsA
MDedge Rheumatology
Current psoriatic lesions or a personal history of psoriasis correlates with PsA disease activity
MDedge Rheumatology